Global Hyaluronic Acid Viscosupplementation Market Size, Share, and COVID-19 Impact Analysis 2023-2029 MedCore - Includes: Single Injection, Two Injections, and 2 more

In 2022, the global hyaluronic acid viscosupplementation market was valued at $2.3 billion. This is expected to grow over the forecast period at a CAGR of 1.9% to reach $2.6 billion.

The full report suite on the global market for hyaluronic acid viscosupplementation includes single injection, two injections, three injections and five injections.

DATA TYPES INCLUDED

• Unit Sales, Average Selling Prices, Market Value & Growth Trends
• Sports Medicine Procedure Volumes
• Market Forecasts Until 2029, and Historical Data to 2022
• Market Drivers & Limiters for each Sports Medicine market segment
• Competitive Analysis with Market Shares for Each Segment
• Recent Mergers & Acquisitions
• Disease Overviews and Demographic Information
• Company Profiles, Product Portfolios and SWOT for Top Competitors

PROCEDURE NUMBERS

Aside from the decline and recovery during 2020 and 2022, associated with the decrease of elective procedures, the total number of hyaluronic acid viscosupplementation procedures is anticipated to grow at a low-single-digit rate over the forecast period.

GLOBAL HYALURONIC ACID VISCOSUPPLEMENTATION MARKET INSIGHTS

Hyaluronic acid products involve one-, two-, three- or five-dose cycles, with the actual number of doses taken often being less than a full treatment. The growth of single-injection products over three- and five-injection products has been the most significant trend in the market. The single injection has, to some extent, cannibalized other injection types; the convenience of the single-injection procedure has aided market penetration.

GLOBAL HYALURONIC ACID VISCOSUPPLEMENTATION MARKET SHARE INSIGHTS

The global orthopedic hyaluronic acid viscoaupplementation market is lead by three main companies: DePuy Synthes, Fidia, and Sanofi. In 2022, DePuy Synthes was the leader in the hyaluronic acid viscosupplementation market due to the success of both MONOVISC® single-injection and ORTHOVISC® three-injection products.

GLOBAL HYALURONIC ACID VISCOSUPPLEMENTATION MARKET SEGMENTATION SUMMARY

• Single Injection
• Two Injections
• Three Injections
• Five Injections

RESEARCH SCOPE SUMMARY

Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)

Base Year: 2022

Forecast: 2023-2029

Historical Data: 2019-2022

Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.

Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.

Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, Internal Database.